Novo Nordisk AS - Company Profile

Powered by

All the sales intelligence you need on Novo Nordisk AS in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Novo Nordisk AS fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Novo Nordisk AS.

Back to companies

Novo Nordisk AS: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

View more

The following section provides information on Novo Nordisk AS’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Novo Nordisk AS's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Lars Rebien Sorensen

Chairman Executive Board Since: 2025 Age: 72

Mr. Lars Rebien Sorensen has been the Chairman of the company since November 2025. Previously, he was the Chairman of Novo Holdings A/S from 2018 to 2025. Previously, he served as President and Chief Executive Officer of Novo Nordisk A/S from 2000 to 2016. He also served as Vice Chair of the Board of Ferring Pharmaceuticals.

Read Hide full bio of Lars Rebien Sorensen

Cees de Jong

Vice Chairman Executive Board Since: 2025 Age: 65

Mr. Cees de Jong has been the Vice Chairman of the company since November 2025.

Read Hide full bio of Cees de Jong

Maziar Mike Doustdar

Chief Executive Officer; President Senior Management Since: 2025 Age: 56

Mr. Maziar Mike Doustdar has been the President and Chief Executive Officer of the company since August 2025. Previously, he was the Executive Vice President of International Operations of the company.

Read Hide full bio of Maziar Mike Doustdar

Karsten Munk Knudsen

Chief Financial Officer; Executive Vice President Senior Management Since: 2018 Age: 55

Mr. Karsten Munk Knudsen has been the Executive Vice President and Chief Financial Officer of the company since 2018. Prior to this, he served as the Senior Vice President of the company. Mr. Knudsen also served as the Corporate Vice President of Finance and IT from 2010 to 2014. He joined Novo Nordisk in 1999 as a Business Analyst in NNIT AS, previously a subsidiary of Novo Nordisk.

Read Hide full bio of Karsten Munk Knudsen

Martin Holst Lange

Chief Scientific Officer; Executive Vice President Senior Management Since: 2025 Age: 56

Mr. Martin Holst Lange has been the Executive Vice President of Research & Development and Chief Scientific Officer of the company since August 2025. Previously, he was the Executive Vice President of Development of the company.

Read Hide full bio of Martin Holst Lange
Gain a 360-degree view of Novo Nordisk AS and make more informed decisions for your business Gain a 360-degree view of Novo Nordisk AS and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer